Loading...

Nika BioTechnology, Inc.

NIKA•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.40
$0.00(0.00%)
U.S. Market opens in 7h 38m

Nika BioTechnology, Inc. (NIKA) Stock Overview

Explore Nika BioTechnology, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap421.1M
P/E Ratio-5512.12
EPS (TTM)N/A
ROE0.29%
Fundamental Analysis

AI Price Forecasts

1 Month$0.65
3 Months$0.37
1 Year Target$0.00

NIKA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Nika BioTechnology, Inc. (NIKA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 34.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5512.12 and a market capitalization of 421.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
5.79%
3-Month Change
3.61%
6-Month Change
34.00%
Year-to-Date (YTD) Change
5.76%
1-Year Change
-59.80%
3-Year Change
101.00%
5-Year Change
101.00%
All-Time (Max) Change
101.00%

Contact Information

https://www.nikapharmaceuticals.com
702 326 3615
2269 Merrimack Valley Avenue, Henderson, NV, 89044

Company Facts

IPO DateMar 14, 2024
CountryUS
Actively Trading

Frequently Asked Questions